AI assistant
REPLIGEN CORP — Director's Dealing 2007
Dec 19, 2007
30826_dirs_2007-12-19_369f5680-eb20-4b7b-b12a-f9fc7061f432.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2007-12-13
Reporting Person: RUSCHE JAMES R (Senior Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2007-12-13 | Common Stock | S | 900 | $6.17 | Disposed | 114974 | Direct |
| 2007-12-13 | c | S | 2357 | $6.15 | Disposed | 112617 | Direct |
| 2007-12-13 | Common Stock | S | 12443 | $6.14 | Disposed | 100174 | Direct |
| 2007-12-13 | Common Stock | S | 2200 | $6.13 | Disposed | 97974 | Direct |
| 2007-12-13 | Common Stock | S | 2100 | $6.12 | Disposed | 95874 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2007-12-13 | Common Stock | $1.41 | M | 30000 | Acquired | 2008-04-29 | Common stock (30000) | Direct |
Footnotes
F1: 7,500 shares exercisable at 4/29/1999, 4/29/2000, 4/29/2001 and 4/29/2002.
F2: Incorrectly reported zero in Part I, Block 5 as the Amount of Securities Beneficially Owned Following Reported Transaction.
F3: Incorrectly reported zero in Part I, Block 5 as the Amount of Securities Beneficially Owned Following Reported Transaction.
F4: Incorrectly reported zero in Part I, Block 5 as the Amount of Securities Beneficially Owned Following Reported Transaction.
F5: Incorrectly reported zero in Part I, Block 5 as the Amount of Securities Beneficially Owned Following Reported Transaction.
F6: Incorrectly left Part II blank. This section should have reflected exercise of 30,000 shares at $1.41 on 12/13/2007.
F7: 7,500 shares exercisable at 4/29/1999, 4/29/2000, 4/29/2001 and 4/29/2002.